The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma

Research output: Contribution to journalReview articlepeer-review

Abstract

In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guidelines, including limits and indications for the use of rhBMP-2. The possible indications for rhBMP-2 in patients undergoing facial trauma are discussed in this article.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalChinese Journal of Traumatology - English Edition
Volume20
Issue number1
DOIs
StatePublished - Feb 1 2017

ASJC Scopus Subject Areas

  • Surgery
  • Orthopedics and Sports Medicine

Keywords

  • Clinical application
  • Maxillofacial trauma
  • Recombinant human bone morphogenetic protein-2

Cite this